Christine Burlein

1.3k total citations
18 papers, 449 citations indexed

About

Christine Burlein is a scholar working on Infectious Diseases, Organic Chemistry and Virology. According to data from OpenAlex, Christine Burlein has authored 18 papers receiving a total of 449 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 6 papers in Organic Chemistry and 6 papers in Virology. Recurrent topics in Christine Burlein's work include HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (6 papers) and Click Chemistry and Applications (5 papers). Christine Burlein is often cited by papers focused on HIV/AIDS drug development and treatment (12 papers), HIV Research and Treatment (6 papers) and Click Chemistry and Applications (5 papers). Christine Burlein collaborates with scholars based in United States and Canada. Christine Burlein's co-authors include Steven S. Carroll, David B. Olsen, Michele Bosserman, Daniel R. McMasters, Shi‐Shan Mao, Malcolm MacCoss, Marija Prhavc, Joanne E. Tomassini, Ashit K. Ganguly and C. Frank Bennett and has published in prestigious journals such as Nature Communications, Analytical Biochemistry and Journal of Medicinal Chemistry.

In The Last Decade

Christine Burlein

18 papers receiving 429 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christine Burlein United States 11 184 182 144 107 98 18 449
Romuald Corbau United Kingdom 14 211 1.1× 240 1.3× 139 1.0× 144 1.3× 179 1.8× 29 711
Giada A. Locatelli Italy 14 398 2.2× 136 0.7× 194 1.3× 61 0.6× 58 0.6× 17 770
Joan Zugay-Murphy United States 8 202 1.1× 130 0.7× 68 0.5× 55 0.5× 44 0.4× 9 363
Melanie Paff United States 13 301 1.6× 295 1.6× 76 0.5× 247 2.3× 386 3.9× 31 751
S. Benzaria France 11 335 1.8× 370 2.0× 139 1.0× 171 1.6× 183 1.9× 25 638
Samantha Zanoli Italy 15 233 1.3× 244 1.3× 279 1.9× 32 0.3× 101 1.0× 23 618
Janet L. Paulsen United States 14 223 1.2× 135 0.7× 75 0.5× 21 0.2× 40 0.4× 16 437
Laurent Bellon United States 16 500 2.7× 98 0.5× 95 0.7× 92 0.9× 70 0.7× 24 667
Kevin M. Cottrell United States 7 173 0.9× 102 0.6× 57 0.4× 211 2.0× 153 1.6× 21 413

Countries citing papers authored by Christine Burlein

Since Specialization
Citations

This map shows the geographic impact of Christine Burlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christine Burlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christine Burlein more than expected).

Fields of papers citing papers by Christine Burlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christine Burlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christine Burlein. The network helps show where Christine Burlein may publish in the future.

Co-authorship network of co-authors of Christine Burlein

This figure shows the co-authorship network connecting the top 25 collaborators of Christine Burlein. A scholar is included among the top collaborators of Christine Burlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christine Burlein. Christine Burlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Adam, Gregory C., Christine Burlein, Steven S. Carroll, et al.. (2023). Discovery of arylsulfonamides as a novel class of allosteric integrase inhibitors with antiviral activity. Bioorganic & Medicinal Chemistry Letters. 89. 129303–129303. 2 indexed citations
2.
Jinn, Sarah, Lihang Yao, Monika Kandebo, et al.. (2021). A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy. Neurobiology of Disease. 159. 105507–105507. 14 indexed citations
3.
Beshore, Douglas C., Gregory C. Adam, Richard J. O. Barnard, et al.. (2021). Redefining the Histone Deacetylase Inhibitor Pharmacophore: High Potency with No Zinc Cofactor Interaction. ACS Medicinal Chemistry Letters. 12(4). 540–547. 14 indexed citations
4.
Hayes, Robert P., Mark Mason, John C. Reid, et al.. (2021). Structural understanding of non-nucleoside inhibition in an elongating herpesvirus polymerase. Nature Communications. 12(1). 3040–3040. 17 indexed citations
5.
Burlein, Christine, Min Xu, Mark W. Stahlhut, et al.. (2017). Discovery of a Distinct Chemical and Mechanistic Class of Allosteric HIV-1 Integrase Inhibitors with Antiretroviral Activity. ACS Chemical Biology. 12(11). 2858–2865. 11 indexed citations
6.
Ganguly, Ashit K., Chih‐Hung Wang, Eun‐Hee Kang, et al.. (2014). Structural optimization of cyclic sulfonamide based novel HIV-1 protease inhibitors to picomolar affinities guided by X-ray crystallographic analysis. Tetrahedron. 70(18). 2894–2904. 33 indexed citations
7.
Burlein, Christine, et al.. (2014). Development of a sensitive amplified luminescent proximity homogeneous assay to monitor the interactions between pTEFb and Tat. Analytical Biochemistry. 465. 164–171. 4 indexed citations
8.
Ganguly, Ashit K., Chih‐Hung Wang, Eun‐Hee Kang, et al.. (2011). Design, Synthesis, and X-ray Crystallographic Analysis of a Novel Class of HIV-1 Protease Inhibitors. Journal of Medicinal Chemistry. 54(20). 7176–7183. 67 indexed citations
9.
Jones, Kristen L., M. Katharine Holloway, Hua-Poo Su, et al.. (2010). Epsilon substituted lysinol derivatives as HIV-1 protease inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(14). 4065–4068. 7 indexed citations
10.
Lu, Meiqing, Winnie Ngo, Ye Mei, et al.. (2010). Purification of untagged HIV-1 reverse transcriptase by affinity chromatography. Protein Expression and Purification. 71(2). 231–239. 10 indexed citations
11.
Rajapakse, Hemaka A., Abbas M. Walji, Keith P. Moore, et al.. (2010). Strategies towards Improving the Pharmacokinetic Profile of ε‐Substituted Lysinol‐Derived HIV Protease Inhibitors. ChemMedChem. 6(2). 253–257. 4 indexed citations
12.
Carroll, Steve S., John A. McCauley, Paul J. Coleman, et al.. (2010). MK-5172, a Novel Macrocyclic Inhibitor of NS3/4a Protease Demonstrates Efficacy Against Viral Resistance in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 86(1). A21–A21. 1 indexed citations
13.
Graham, Donald J., L K Handt, Christine Fandozzi, et al.. (2008). Evaluation of MK-7009, A Novel Macrocyclic Inhibitor of NS3/4A Protease, in the Chimpanzee Model of Chronic Hepatitis C Virus Infection. Antiviral Research. 78(2). A23–A23. 2 indexed citations
14.
Butora, Gabor, David B. Olsen, Steven S. Carroll, et al.. (2007). Synthesis and HCV inhibitory properties of 9-deaza- and 7,9-dideaza-7-oxa-2′-C-methyladenosine. Bioorganic & Medicinal Chemistry. 15(15). 5219–5229. 24 indexed citations
15.
Mao, Shi‐Shan, Jillian DiMuzio, Carolyn McHale, et al.. (2007). A time-resolved, internally quenched fluorescence assay to characterize inhibition of hepatitis C virus nonstructural protein 3–4A protease at low enzyme concentrations. Analytical Biochemistry. 373(1). 1–8. 23 indexed citations
16.
Eldrup, Anne B., Charles Allerson, C. Frank Bennett, et al.. (2004). Structure−Activity Relationship of Purine Ribonucleosides for Inhibition of Hepatitis C Virus RNA-Dependent RNA Polymerase. Journal of Medicinal Chemistry. 47(9). 2283–2295. 153 indexed citations
17.
Mao, Shi‐Shan, Dennis Colussi, Michele Bosserman, et al.. (2003). Electrochemiluminescence assay for basic carboxypeptidases: inhibition of basic carboxypeptidases and activation of thrombin-activatable fibrinolysis inhibitor. Analytical Biochemistry. 319(1). 159–170. 27 indexed citations
18.
Barrow, James C., Philippe G. Nantermet, Shaun R. Stauffer, et al.. (2003). Synthesis and Evaluation of Imidazole Acetic Acid Inhibitors of Activated Thrombin-Activatable Fibrinolysis Inhibitor as Novel Antithrombotics. Journal of Medicinal Chemistry. 46(25). 5294–5297. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romuald Corbau Breakdown of academic impact, for papers by Giada A. Locatelli Breakdown of academic impact, for papers by Joan Zugay-Murphy Breakdown of academic impact, for papers by Melanie Paff Breakdown of academic impact, for papers by S. Benzaria Breakdown of academic impact, for papers by Samantha Zanoli Breakdown of academic impact, for papers by Janet L. Paulsen Breakdown of academic impact, for papers by Laurent Bellon Breakdown of academic impact, for papers by Kevin M. Cottrell
Rankless by CCL
2026